Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pterygium vascularity and size before and after
intralesional ranibizumab injection and to evaluate its recurrence rate following pterygium
excision surgery.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Universiti Sains Malaysia University of Science Malaysia